Bureaucracy Has Delayed Plans For Three FDA Offices In China, HHS Secretary Leavitt Says
Main Category: Pharma Industry / Biotech IndustryAlso Included In: Public Health
Article Date: 28 May 2008 - 9:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
HHS Secretary Mike Leavitt on Friday said that Chinese bureaucracy has delayed plans to establish FDA offices in three cities -- Beijing, Shanghai and Guangzhou -- that would monitor exports of food, medications, medical devices and other consumer products to the U.S., the Associated Press reports. Leavitt said that the Chinese Ministry of Foreign Affairs must formally approve the plans, after which the agency will begin the process of approval of diplomatic visas for the 13 FDA employees who will staff the offices.
In addition to China, Leavitt said that he hopes to establish FDA offices in India. He said, "There are 90 to 100 FDA-inspected facilities there producing mostly drugs and medical devices," adding, "I expect that number to grow. The connection between the U.S. pharmaceutical industry and India is real and expanding. We just need to be there."
Leavitt also said that he might seek to establish FDA offices in Central America (Associated Press, 5/23). According to Leavitt, Central America exports a large amount of fruits and vegetables to the U.S. He said that he plans to discuss the issue, as well as other concerns related to food safety, with health officials from El Salvador, Guatemala, Panama and other Central American nations at a conference in June (Rockoff, Baltimore Sun, 5/24).
Leavitt also addressed the recent Senate approval of a supplemental war appropriations bill that would provide an additional $275 million for FDA. The additional funds "could be well deployed," he said (Associated Press, 5/23).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/108940.php>
APA
http://www.medicalnewstoday.com/releases/108940.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



